Physician profile
Tiffany Chen
NPI 1467121558
$2,754.81
in general payments reported to CMS, 2019-2025
17 companies · $949 in 2025
The $949 reported for 2025 was more than what 84% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.76 · 2022: $206 · 2023: $513 · 2024: $1,001 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,463.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $810.99 | 2021-2025 | Cequa |
| Alcon Vision LLC | $586.65 | 2022-2025 | Clareon, Rocklatan, Clareon Panoptix Pro |
| Glaukos Corporation | $474.53 | 2023-2025 | Radius |
| Horizon Therapeutics Plc | $169.33 | 2023 | Tepezza |
| Bausch & Lomb Americas INC. | $147.34 | 2022-2025 | Miebo, Vyzulta |
| Amgen INC. | $126.38 | 2024-2025 | Tepezza |
| Sight Sciences, INC. | $71.19 | 2024 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $55.80 | 2025 | Xdemvy |
| Rxsight INC | $55.11 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Mallinckrodt Hospital Products INC. | $53.45 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $49.43 | 2024-2025 | Tecnis Simplicity, Amo Phaco Needle |
| Abbvie INC. | $49.40 | 2022 | |
| Dompe US, INC. | $26.09 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.46 | 2021 | |
| Thea Pharma INC. | $22.63 | 2025 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.34 | 2022 | |
| Aerie Pharmaceuticals, INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.